LMWX 40

LMWX 40 Specification

Pacakaging (Quantity Per Box)
1 prefilled syringe (0.4 ml)

Life Span
Refer to expiry date on pack

Origin of Medicine
India

Dosage Form
Injectable solution

Salt Composition
Enoxaparin Sodium - 40 mg

Indication
Prevention of thromboembolic disorders

Brand Name
LMWX 40

Packaging Type
Prefilled Syringe

Drug Type
Low Molecular Weight Heparin

Ingredients
Enoxaparin Sodium

Physical Form
Injection (liquid)

Function
Anticoagulant (prevention of blood clots)

Recommended For
Prevention of Venous Thromboembolism

Dosage
As directed by the physician

Dosage Guidelines
As prescribed by the healthcare practitioner

Suitable For
Adults

Quantity
0.4 ml

Storage Instructions
Store below 25C, protect from light

Manufacturing License Number
As per label

Marketed By
Indoco Remedies Ltd.

Route of Administration
Subcutaneous injection

Strength
40 mg

Regulatory Status
Approved

Color
Colorless to pale yellow solution

Therapeutic Class
Antithrombotic

Prescription Required
Yes

LMWX 40 Trade Information

Minimum Order Quantity
1000 Boxes

Supply Ability
1000 Boxes Per Day

Delivery Time
1 Days

About LMWX 40

Order Today and experience the impeccable efficacy of LMWX 40, a low molecular weight heparin manufactured by Swiss Parenterals Ltd. With an incomparable formulation containing 40 mg of Enoxaparin Sodium per 0.4 ml, it is presented in an excellent prefilled syringe for easy subcutaneous injection. Buy now and utilise offer pricing for this prescription-only anticoagulant designed for the prevention of venous thromboembolism in adults. Each clear to pale yellow solution adheres to top safety standards and is packaged for uncompromising quality and patient safety. Consult your healthcare provider for personalised dosage.

Application Excellence and Versatile Suitability

LMWX 40 is notably suitable for hospitals, clinics, and healthcare settings requiring the prevention of thromboembolic disorders. The plant application focuses on delivering precise anticoagulant therapy to adults, with the site of application being subcutaneous-typically administered in the abdomen or thigh. This injectable solution ensures reliable efficacy for patients at risk of blood clots, providing healthcare practitioners with a trustworthy and industry-leading option for venous thromboembolism prevention.

Sample Policy, Certifications, and Reliable Delivery

Our LMWX 40 orders are supported by an exchange-friendly sample policy, bringing peace of mind with each purchase. Products come with requisite certifications, ensuring compliance and quality. Packaging integrity is prioritised during every transaction, from storage under controlled conditions to careful transportation. Delivery time depends on destination but is managed efficiently for optimal customer satisfaction. Our dedication to secure packaging and swift logistics ensures every prefilled syringe arrives in excellent condition.

FAQ's of LMWX 40:

Q: How is LMWX 40 administered?

A: LMWX 40 is administered as a subcutaneous injection, usually in the abdomen or thigh, as directed by a healthcare practitioner.

Q: What are the main benefits of using LMWX 40?

A: The main benefit is the prevention of venous thromboembolism, reducing the risk of dangerous blood clots in at-risk adults.

Q: When should I use LMWX 40?

A: LMWX 40 should be used according to your physician's instructions, typically for prevention of thromboembolic disorders in adults who are at risk.

Q: Where can I purchase LMWX 40?

A: LMWX 40 can be purchased at licensed pharmacies on presentation of a prescription from a registered medical practitioner.

Q: What precautions should I take during usage?

A: You should use LMWX 40 strictly under medical supervision, watch for signs of bleeding or irritation at the injection site, and store it below 25C, protected from light.

Q: Is there an exchange or sample policy for LMWX 40?

A: Sample and exchange policies are available subject to distributor terms and compliance verification for the packaging integrity and batch authenticity.